Cargando…
Mesenchymal stem cells in acute lung injury: are they ready for translational medicine?
Acute lung injury (ALI) is a severe clinical condition responsible for high mortality and the development of multiple organ dysfunctions, because of the lack of specific and effective therapies for ALI. Increasing evidence from pre-clinical studies supports preventive and therapeutic effects of mese...
Autores principales: | Xu, Feng, Hu, Yue, Zhou, Jiebai, Wang, Xiangdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780529/ https://www.ncbi.nlm.nih.gov/pubmed/23834470 http://dx.doi.org/10.1111/jcmm.12063 |
Ejemplares similares
-
Translational medicine as a permanent glue and force of clinical medicine and public health: perspectives (1) from 2012 Sino-American symposium on clinical and translational medicine
por: Zhou, Jiebai, et al.
Publicado: (2012) -
Mechanisms of interactions between lung‐origin telocytes and mesenchymal stem cells to treat experimental acute lung injury
por: Zhang, Ding, et al.
Publicado: (2020) -
Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer
por: Zhou, Jiebai, et al.
Publicado: (2014) -
Mesenchymal stem cells shift the pro-inflammatory phenotype of neutrophils to ameliorate acute lung injury
por: Feng, Bing, et al.
Publicado: (2023) -
Mesenchymal Stem Cells as Promoters, Enhancers, and Playmakers of the Translational Regenerative Medicine
por: Ballini, Andrea, et al.
Publicado: (2017)